New Key Statistics Module, Z-Score and F-Score
HKSE:09969 Key Ratios
Market Cap HK$ M | 14,670.19 |
Enterprise Value HK$ M | 7,591.33 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 1.64 |
Price/Sales | 12.29 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) HK$ M | 979.00 |
EPS (TTM) HK$ | -0.24 |
Beneish M-Score | -0.4 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -18.87 |
EV-to-EBITDA | -19.29 |
PEG | -- |
Shares Outstanding M | 1,762.57 |
Net Margin (%) | -41.62 |
Operating Margin % | -62.29 |
Pre-tax Margin (%) | -43.25 |
Quick Ratio | 3.77 |
Current Ratio | 3.82 |
ROA % (ttm) | -3.79 |
ROE % (ttm) | -5.24 |
ROIC % (ttm) | -19.52 |
Dividend Yield % | -- |
Altman Z-Score | 2.52 |
HKSE:09969 Number of Guru Trades
HKSE:09969 Volume of Guru Trades
Gurus Latest Trades with HKSE:09969
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
HKSE:09969 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
InnoCare Pharma Ltd Insider Transactions
No Available Data